ArticleClinical hypertension2026
Evaluation of guideline adherence to hypertension-mediated organ damage screening in Korean patients with hypertension: results from the Korean Registry of Target Organ Damage in Hypertension (KorHR).
Article in Clinical hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01861080 (Observational Study of Clinical Characteristics and Prognostic Factors of Korean Hypertensives), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Observational Study of Clinical Characteristics and Prognostic Factors of Korean Hypertensives
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence in Cardiovascular Medicine: Focus on Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adherence to guidelines for hypertension-mediated organ damage (HMOD) assessment has not been extensively studied. We aimed to evaluate guideline adherence to HMOD assessment and to identify factors associated with this adherence. Methods: In this prospective, multicenter observational study conducted from May 2013 to December 2022, we evaluated adherence to guideline-recommended HMOD screening among 2,070 hypertensive patients enrolled from 24 tertiary care centers in Korea. Patients were categorized as either newly treated or on treatment. The basic screening tests included urine albumin-to-creatinine ratio (UACR), electrocardiography (ECG), and glomerular filtration rate (GFR). The extended screening tests included echocardiography, carotid ultrasonography, fundoscopic examination, ankle-brachial index measurement, and brachial-ankle pulse wave velocity assessment. Results: The overall adherence rate for basic screening was 68.4%. Compliance with GFR and ECG assessments was high (90.3% and 95.2%, respectively), whereas adherence to UACR testing was lower (72.5%). The adherence rate for basic screening was significantly lower in the on-treatment group compared with the newly treated group (57.1% vs. 79.9%). Elderly patients (≥ 60 years) exhibited the lowest adherence to basic screening. Further analyses revealed that increasing age was significantly associated with a lower likelihood of completing both basic and extended screenings. Conclusions: Guideline-recommended HMOD screening remains underutilized in routine clinical practice, particularly among elderly patients. These findings underscore the need to improve adherence to HMOD screening. Trial Registration: ClinicalTrials.gov Identifier: NCT01861080.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.